Segui
Filippo SCHEPIS
Filippo SCHEPIS
Affiliazione sconosciuta
Email verificata su unimore.it
Titolo
Citata da
Citata da
Anno
Baveno VII–renewing consensus in portal hypertension
R De Franchis, J Bosch, G Garcia-Tsao, T Reiberger, C Ripoll, ...
Journal of hepatology 76 (4), 959-974, 2022
14922022
Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials
C Camma, F Schepis, A Orlando, M Albanese, L Shahied, F Trevisani, ...
Radiology 224 (1), 47-54, 2002
10712002
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis
E Villa, C CammÓ, M Marietta, M Luongo, R Critelli, S Colopi, C Tata, ...
Gastroenterology 143 (5), 1253-1260. e4, 2012
8132012
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis
F Fiorica, D Di Bona, F Schepis, A Licata, L Shahied, A Venturi, AM Falchi, ...
Gut 53 (7), 925-930, 2004
7522004
Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?
F Schepis, C CammÓ, D Niceforo, A Magnano, S Pallio, M Cinquegrani, ...
Hepatology 33 (2), 333-338, 2001
5562001
Q‐T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors
M Bernardi, S Calandra, A Colantoni, F Trevisani, ML Raimondo, G Sica, ...
Hepatology 27 (1), 28-34, 1998
5031998
Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years
M Manno, C CammÓ, F Schepis, F Bassi, R Gelmini, F Giannini, F Miselli, ...
Gastroenterology 127 (3), 756-763, 2004
3562004
MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1
A Bellacosa, L Cicchillitti, F Schepis, A Riccio, AT Yeung, Y Matsumoto, ...
Proceedings of the National Academy of Sciences 96 (7), 3969-3974, 1999
3431999
Effect of peginterferon alfa‐2a on liver histology in chronic hepatitis C: a meta‐analysis of individual patient data
C Camma, D Di Bona, F Schepis, EJ Heathcote, S Zeuzem, PJ Pockros, ...
Hepatology 39 (2), 333-342, 2004
3272004
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study
E Villa, R Critelli, B Lei, G Marzocchi, C CammÓ, G Giannelli, P Pontisso, ...
Gut 65 (5), 861-869, 2016
2362016
The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity
S Cortellino, D Turner, V Masciullo, F Schepis, D Albino, R Daniel, ...
Proceedings of the National Academy of Sciences 100 (25), 15071-15076, 2003
1652003
When and how to treat acute hepatitis C?
A Licata, D Di Bona, F Schepis, L Shahied, A Craxı̀, C CammÓ
Journal of hepatology 39 (6), 1056-1062, 2003
1422003
Consensus conference on TIPS management: techniques, indications, contraindications
S Fagiuoli, R Bruno, WD Venon, F Schepis, F Vizzutti, P Toniutto, ...
Digestive and Liver Disease 49 (2), 121-137, 2017
1362017
Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors
D Di Vizio, L Cito, A Boccia, P Chieffi, L Insabato, G Pettinato, ML Motti, ...
Oncogene 24 (11), 1882-1894, 2005
1342005
Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis
L Turco, G Garcia-Tsao, I Magnani, M Bianchini, M Costetti, C Caporali, ...
Journal of hepatology 68 (5), 949-958, 2018
1312018
Liver Angiopoietin‐2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct‐Acting Antivirals
F Faillaci, L Marzi, R Critelli, F Milosa, F Schepis, E Turola, S Andreani, ...
Hepatology 68 (3), 1010-1024, 2018
1232018
Validating, deconstructing and refining Baveno criteria for ruling out high‐risk varices in patients with compensated cirrhosis
P Jangouk, L Turco, A De Oliveira, F Schepis, E Villa, G Garcia‐Tsao
Liver International 37 (8), 1177-1183, 2017
1202017
Under-dilated TIPS associate with efficacy and reduced encephalopathy in a prospective, non-randomized study of patients with cirrhosis
F Schepis, F Vizzutti, G Garcia-Tsao, G Marzocchi, L Rega, N De Maria, ...
Clinical Gastroenterology and Hepatology 16 (7), 1153-1162. e7, 2018
1132018
Protection of human endothelial cells from oxidative stress: role of Ras-ERK1/2 signaling
G Cuda, R Patern˛, R Ceravolo, M Candigliota, N Perrotti, F Perticone, ...
Circulation 105 (8), 968-974, 2002
1092002
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease
A Sartini, S Gitto, M Bianchini, MC Verga, M Di Girolamo, A Bertani, ...
Cell death & disease 9 (2), 87, 2018
932018
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20